On July 9th, the Chinese herbal medicine index was 2,709 points, unchanged from yesterday, a decrease of 1.53% from the cycle's highest point of 2,751 points (2023-06-26), and an increase of 177.85% from the lowest point of 975 points on November 25th, 2019. (Note: The cycle refers to June 30th, 2019 to present)

According to the price monitoring of SunSirs, in the 27th week of 2023 (7.3-7.7), there were 2 products that rose, 2 products that fell, and 4 products that rose or fell to 0 on the Chinese herbal medicine price list. The main commodities that rose were: Ophiopogon japonicus (1.21%) and Flos Lonicerae (1.06%); The main commodities that fell were: Forsythia (-2.41%) and Angelica (-1.85%). Last week's average increase or decrease was -0.25%.

According to the monitoring of the commodity market analysis system of SunSirs, some Angelica plants bolting in Gansu production areas is relatively serious, which will affect the later root growth and attract attention from many businesses. The growth situation in the later stage still needs further observation. The market is constrained by high prices, and the recent supply movement is not fast, and there has been a slight decrease. The price of bulk goods is between 160 and 165 RMB.

The volume of goods sold in the Minxian market has slightly increased, with high market traffic and low trading volume, resulting in a stable transaction price. The transaction price of Danggui Pharmaceuticals is between 145-150 RMB/kg (substandard), the transaction price of high-quality pharmaceutical products is between 152-156 RMB/kg, and the transaction price of Danggui Xiaotiao is between 158-163 RMB/kg; The transaction price of Danggui Zhongtiao is between 170-175 RMB/kg; The transaction price of Angelica large bars (with good bars) is above 178 RMB/kg

At present, it is the growth period of Angelica seedlings, and news has come from the production area that many plots have experienced bolting and natural disasters such as hail. However, the price of Angelica is already at a historical high, and buyers are basically on the sidelines. The price of Angelica has slightly declined, but at the same time, holders have a strong reluctance to sell and are unwilling to sell at a lower price. Business analysis suggests that the price of Angelica will not drop significantly in the short term. As for whether there can be a higher market for Angelica in the future, it depends on the size of new product production this year and the actual market demand. Regardless of the future trend of Angelica, it is still expected to operate at high prices after production.

With the continuous high temperature weather throughout the country, the Chinese herbal medicine market has entered the traditional off-season, with low overall trading volume, limited market hotspots, and limited attention from merchants. Some varieties that missed the price increase in the early stage have performed well in the near future, but clearly lack the drive of star varieties; The trading volume of the declining variety market this week has further shrunk, lacking practical digestion, and merchants are also unwilling to sell at reduced prices.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.